Global Pains Lead To Transformative Strategies
In this, the 6th annual UPS Pain in the (Supply) Chain survey, evidence emerges of a coming shift in the healthcare supply chain, as executives look to their supply chains to drive business change and meet business goals. Learn more.
By Stephen McIndoe, BEng, CEng, MIET, VP Consulting, Be4ward
My previous article discussed the core artwork process and the other company processes it may interface with or be supported by. In this article, I will look at how roles are structured to support the process and the governance that needs to be put in place to lead the process.
By Rebecca Vangenechten, Life Sciences Industry Consultant, Siemens; and Ivo Backx, Senior Consultant for Drug Manufacturing, Vertical Market Management Pharma Department, Industrial Automation and Drives Technology at Siemens
Pharmaceutical secondary manufacturing has long stood in stark contrast to the drug discovery end of the business, as well as to other sectors, when it comes to innovation such as continuous manufacturing. Is that about to change?
By Robert McGregor, Global Marketing and High-End Product Manager, Brookfield Engineering Laboratories, Inc.
How do you bring consistency to QC testing? Pharmaceutical products that meet manufacturability criteria and provide high-level consumer satisfaction undergo a battery of tests before being distributed to the consumer. Using affordable instrumentation to perform QC tests, which certify that tablets, capsules, elixirs, ointments, etc. have the right physical properties, is essential for today’s successful business.
By Paul Held, Ph.D., and Peter Banks, Ph.D., BioTek Instruments, Inc.
Transient transfection of tissue culture cells is a routine method to introduce novel genetic elements into cultured cells. While there are numerous methods to introduce foreign DNA into tissue culture cells, the efficacy of the experimental results is dependent on adequate expression of the introduce gene.
By Richard Mirro, Eppendorf Inc.
This application report presents a simple protocol for achieving high-density culture of Sf-9 insect cells using a New Brunswick benchtop, autoclavable, stirred-tank bioreactor.
By James Drinkwater, Bioquell Inc.
Biocontamination found in critical zones within processing environments can affect the whole process and sterility of the final products, potentially putting patients at risk. This can lead to significant financial costs and impact operational resources.
By Gary Partington, Walker Barrier Systems
While price is certainly an important reason for buying any piece of capital equipment, it is not always the top reason. There are important considerations to examine, when selecting an isolator supplier, to be certain that you are getting what you are paying for, before the purchase order is written.
By Todd Keefe, Southwest Airlines Cargo
The ecosystem tied to the movement of medical and pharmaceutical products is complex and highly distributed. Shippers and receivers for these life-saving products are spread out around the country, and there are no centralized routes between them.
By Bill Dudenhoefer, Eriez
Many manufacturers today invest thousands — if not millions — of dollars annually into magnetic separation equipment, proactively reducing the risk that any foreign object or contaminant will be mixed in with a product sold to their network of customers, including other OEMs, distributors, or directly to consumers.